Ralpancizumab (Anti-PCSK9)

製品コード：A3022        

印刷

Ralpancizumab (Anti-PCSK9) is a monoclonal antibody targeting selective proprotein convertase subtilisin kexin 9 (PCSK9). It has the potential in hemorrhagic stroke, hypercholesterolemic, dyslipidemia treatment. MW 145.28 KD.

製品説明

CAS No. 1407495-04-8
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Isotype Human IgG2SA
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions

人間や獣医の診断であるか治療的な使用のためにでない。